The team of GSK Stockmann, led by Dr. Philipp M\u00f6ssner, advised Grand City Properties S.A. (GYC) on the Luxembourg law aspects of increasing its stake in LEG Immobilien to 20.04 %, making GYC the largest shareholder in the D\u00fcsseldorf-based residential property company. The stake is worth more than EUR 700 million.<\/p>\n\n\n\n
<\/p>\n\n\n\n
The transaction reflects the strategy of Aroundtown SA, GYC\u2019s majority shareholder, to expand its residential property business. With the investment, residential property becomes Aroundtown\u2019s largest business segment, at 42 % of its portfolio. According to the company, the investment completes the build-out of its residential division.<\/p>\n\n\n\n
<\/p>\n\n\n\n
GSK Stockmann provided comprehensive advice to GYC on the Luxembourg law aspects of the transaction, covering capital markets, corporate law and related financing matters.<\/p>\n\n\n\n
<\/p>\n\n\n\n
Listed on Frankfurt Stock Exchange (Germany) under the ticker GYC, Grand City Properties S.A. is a specialist residential real estate company focused on investing in, managing, and renting income-generating properties. Strategically headquartered in Luxembourg, its main operations are concentrated across densely populated urban areas in Germany, the United Kingdom, and internationally.<\/p>\n\n\n\n
<\/p>\n\n\n\n
GSK Stockmann Luxembourg legal advisers:<\/strong> The team of GSK Stockmann, led by Dr. Philipp M\u00f6ssner, advised Grand City Properties S.A. (GYC) on the Luxembourg law aspects of increasing its stake in LEG Immobilien to 20.04 %, making GYC the largest shareholder in the D\u00fcsseldorf-based residential property company. The stake is worth more than EUR 700 million. The transaction reflects the … Continued<\/a><\/p>\n","protected":false},"author":23,"featured_media":32210,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[635],"tags":[],"ausgabe":[660],"class_list":["post-34006","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-deal-news","ausgabe-gsk-luxembourg"],"acf":{"postdownloads_lux":[{"download_lux":34007,"anzeigetitel_lux":"DOWNLOAD"}],"pressekontakt":{"name":"Beate D\u00fcnschede","email":"beate.duenschede@gsk-lux.com","phone":"+352 271802-29"},"ansprechpartner":[{"anwalt":30548},{"anwalt":30545},{"anwalt":30555},{"anwalt":30536}]},"_links":{"self":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts\/34006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/comments?post=34006"}],"version-history":[{"count":1,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts\/34006\/revisions"}],"predecessor-version":[{"id":34008,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts\/34006\/revisions\/34008"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/media\/32210"}],"wp:attachment":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/media?parent=34006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/categories?post=34006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/tags?post=34006"},{"taxonomy":"ausgabe","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/ausgabe?post=34006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Dr. Philipp M\u00f6ssner (Lead Partner, Capital Markets, Corporate and Finance), Chara Papagiannidi (Counsel, Corporate, Capital Markets), Andrea Carraretto (Senior Associate, Corporate and Finance), Maria Gusinski (Associate, Corporate, Capital Markets)<\/p>\n","protected":false},"excerpt":{"rendered":"